News/Interviews

New FDA-Approved Pergolide Product

A new FDA-approved Pergolide product offers options in the management of clinical signs associated with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing's disease.

  • Email
  • Favorite
  • Share
  • Newsletters